Pfizer said Thursday it is reviving development of its melanoma drug tremelimumab through a collaboration with Swiss drugmaker Debiopharm. http://finance.yahoo.com/news/Pfizer-enters-melanoma-apf-1895588390.html?x=0&.v=1